2025
Targeting problem-solving with a cognitive remediation intervention for suicide prevention in veterans: A pilot study
Goldstein K, Medalia A, Nicholas E, Pietrzak R, Ahmed T, Haznedar M, Sweeney R, Wrobleski J, Dichiara A, Challman K, McClure M, Hazlett E. Targeting problem-solving with a cognitive remediation intervention for suicide prevention in veterans: A pilot study. Military Psychology 2025, ahead-of-print: 1-10. PMID: 40262555, DOI: 10.1080/08995605.2025.2494868.Peer-Reviewed Original ResearchSuicidal behaviorCognitive remediationDepressive disorderHistory of suicidal behaviorCognitive remediation interventionsSuicide risk reductionPost-treatmentAdaptive functioning outcomesAssociated with greater reductionsProblem-solvingSuicidal ideation/behaviorCognitive deficitsTherapy fidelityBrief formatRemedial interventionsVeteran outpatientsSuicide preventionEffect sizeGreater improvementFollow-up time pointsGreater reductionsControl conditionVeteransPilot dataDepression
2024
Race/ethnicity and socioeconomic status as predictors of outcome following family therapy in youth at clinical high risk for psychosis
Ruiz‐Yu B, Le T, Weintraub M, Zinberg J, Addington J, O'Brien M, Walsh B, Friedman‐Yakoobian M, Auther A, Cornblatt, Domingues I, Cannon T, Miklowitz D, Bearden C. Race/ethnicity and socioeconomic status as predictors of outcome following family therapy in youth at clinical high risk for psychosis. Early Intervention In Psychiatry 2024, 18: 981-990. PMID: 38676463, PMCID: PMC11512687, DOI: 10.1111/eip.13541.Peer-Reviewed Original ResearchClinical high riskNegative symptomsFamily therapyRandomized trial of family-focused therapyGlobal functioningEffect of race/ethnicityNHW participantsTrial of family therapyFamily-focused therapyParental educationAssociated with greater improvementSociodemographic factorsSocioeconomic statusPositive symptomsPsychosocial treatmentsPsychosocial functioningHigher parental educationFollow-up measurementsHigh riskInfluence of race/ethnicityGreater improvementRandomized trialsTreatment outcomesPsychosisPredictors of outcomePrediction of the efficacy of group cognitive behavioral therapy using heart rate variability based smart wearable devices: a randomized controlled study
Lin Z, Zheng J, Wang Y, Su Z, Zhu R, Liu R, Wei Y, Zhang X, Wang F. Prediction of the efficacy of group cognitive behavioral therapy using heart rate variability based smart wearable devices: a randomized controlled study. BMC Psychiatry 2024, 24: 187. PMID: 38448895, PMCID: PMC10916138, DOI: 10.1186/s12888-024-05638-x.Peer-Reviewed Original ResearchConceptsGroup cognitive behavioral therapyWait-list controlCognitive behavioral therapyBehavioral therapyEfficacy of group cognitive behavioral therapyGroup cognitive behavioural therapy groupDisabling mental health problemPredictors of treatment responseAssociated with greater improvementTreatment outcomesAssociated with depressionHigher heart rate variabilityMental health problemsHeart rate variabilityAnxious symptomsAnxiety symptomsParticipants' symptomsCollege studentsHRV levelsAnxietyTrial registrationThe trialSignificant public health concernDepressionGreater improvementHeart rate variability parameters
2023
Impact of youth lay health workers on HIV service delivery in South Africa: A pragmatic cluster randomized trial of the Youth Health Africa program
Tollefson D, Dasgupta S, Setswe G, Reeves S, Charalambous S, Duerr A. Impact of youth lay health workers on HIV service delivery in South Africa: A pragmatic cluster randomized trial of the Youth Health Africa program. PLOS ONE 2023, 18: e0294719. PMID: 38033029, PMCID: PMC10688901, DOI: 10.1371/journal.pone.0294719.Peer-Reviewed Original ResearchConceptsHIV service deliveryHIV testingTreatment initiationIntervention facilitiesHealth workersYoung adultsAdolescents/young adultsProportion of patientsPragmatic clusterSecondary outcomesHIV positivityPrimary outcomeTreat analysisHIV servicesHIV programsHealth facilitiesHIVBaseline outcomesTrialsService deliveryNull trialsCareImmediate increaseOutcomesGreater improvementThe effect of 12-month postoperative weight change on outcomes following midurethral sling for stress urinary incontinence: a secondary analysis of the ESTEEM and TOMUS randomized trials
Getaneh F, Ringel N, Kolm P, Iglesia C, Dieter A. The effect of 12-month postoperative weight change on outcomes following midurethral sling for stress urinary incontinence: a secondary analysis of the ESTEEM and TOMUS randomized trials. International Urogynecology Journal 2023, 34: 2809-2816. PMID: 37750917, DOI: 10.1007/s00192-023-05654-7.Peer-Reviewed Original ResearchConceptsMixed urinary incontinenceStress urinary incontinencePostoperative weight changeMidurethral slingUrinary incontinenceSUI curePrimary outcomeUUI episodesWeight changeBody weightHigher baseline body mass indexTreatment of SUISecondary analysisBaseline body mass indexWeight gainWeight lossSUI cure ratesMulticenter randomized trialImpact of obesityBody mass indexHigh smoking ratesMethodsThis secondary analysisGreater improvementMUS placementPerioperative variablesEvaluation of the “Rethink Stress” Mindset Intervention: A Metacognitive Approach to Changing Mindsets
Crum A, Santoro E, Handley-Miner I, Smith E, Evans K, Moraveji N, Achor S, Salovey P. Evaluation of the “Rethink Stress” Mindset Intervention: A Metacognitive Approach to Changing Mindsets. Journal Of Experimental Psychology General 2023, 152: 2603-2622. PMID: 37199967, DOI: 10.1037/xge0001396.Peer-Reviewed Original ResearchConceptsMetacognitive approachMindset interventionNature of stressSelf-report measuresPhysical health symptomsStress mindsetMetacognitive informationMindset manipulationWaitlist controlExperiment 3Experiment 1Experiment 2Health symptomsAdaptive mindsetTraditional interventionsGreater initial increaseMindsetPersonal experienceContradictory informationParticipantsInterventionMedia portrayalsGreater improvementFaceEmployeesScalp hair regrowth is associated with improvements in health-related quality of life and psychological symptoms in patients with severe alopecia areata: results from two randomized controlled trials
Piraccini B, Ohyama M, Craiglow B, Bewley A, Ding Y, Chen Y, Dutronc Y, Pierce E, Durand F, Mostaghimi A. Scalp hair regrowth is associated with improvements in health-related quality of life and psychological symptoms in patients with severe alopecia areata: results from two randomized controlled trials. Journal Of Dermatological Treatment 2023, 34: 2227299. PMID: 37381691, DOI: 10.1080/09546634.2023.2227299.Peer-Reviewed Original ResearchConceptsSevere alopecia areataHealth-related qualityHair regrowthAlopecia areataMinimal regrowthBaseline Hospital AnxietyProportion of patientsPhase 3 trialDepression Scale scoresGreater improvementBaricitinib 2Daily placeboMore patientsWeek 36Hospital AnxietyTreatment allocationSkindex-16PatientsScale scoreScore changePsychological symptomsPsychological burdenAreataTrialsAmygdala downregulation training using fMRI neurofeedback in post-traumatic stress disorder: a randomized, double-blind trial
Zhao Z, Duek O, Seidemann R, Gordon C, Walsh C, Romaker E, Koller W, Horvath M, Awasthi J, Wang Y, O’Brien E, Fichtenholtz H, Hampson M, Harpaz-Rotem I. Amygdala downregulation training using fMRI neurofeedback in post-traumatic stress disorder: a randomized, double-blind trial. Translational Psychiatry 2023, 13: 177. PMID: 37230984, PMCID: PMC10209552, DOI: 10.1038/s41398-023-02467-6.Peer-Reviewed Original ResearchConceptsPost-traumatic stress disorderControl groupAmygdala activityPTSD treatmentDouble-blind clinical trialStress disorderDouble-blind trialSecondary outcome measurementsTrauma recallNeurofeedback trainingGreater improvementAmygdala controlsPotential clinical applicationsSymptom scoresActive groupClinical trialsTreatment successOutcome measurementsTrauma scriptsSymptom reductionNeurofeedback interventionPTSD symptomsFMRI neurofeedbackAmygdalaNeural markersTreatment of plaque psoriasis with deucravacitinib (POETYK PSO-2 study): a plain language summary
Strober B, Thaçi D, Sofen H, Kircik L, Gordon K, Foley P, Rich P, Paul C, Bagel J, Colston E, Throup J, Kundu S, Sekaran C, Linaberry M, Banerjee S, Papp K. Treatment of plaque psoriasis with deucravacitinib (POETYK PSO-2 study): a plain language summary. Immunotherapy 2023, 15: 787-797. PMID: 37150956, DOI: 10.2217/imt-2023-0062.Peer-Reviewed Original ResearchConceptsSevere plaque psoriasisPlaque psoriasisSide effectsNew treatmentsBasic everyday tasksCommon side effectsMonths of treatmentUndesirable side effectsPatch of skinDaily pillPsoriasis treatmentClinical trialsPlaceboPsoriasisDeucravacitinibLarger studyTreatmentApremilastGreater improvementMore participantsSimilar ratesPillsMedical journalsParticipantsSimilar numberRandomized controlled trial of the glycine transporter 1 inhibitor PF-03463275 to enhance cognitive training and neuroplasticity in schizophrenia
Surti T, Ranganathan M, Johannesen J, Gueorguieva R, Deaso E, Kenney J, Krystal J, D'Souza D. Randomized controlled trial of the glycine transporter 1 inhibitor PF-03463275 to enhance cognitive training and neuroplasticity in schizophrenia. Schizophrenia Research 2023, 256: 36-43. PMID: 37141764, PMCID: PMC10257994, DOI: 10.1016/j.schres.2023.04.010.Peer-Reviewed Original ResearchConceptsGlycine transporter 1Cytochrome P450 2D6 extensive metabolizersGlyT1 inhibitorsWeeks of washoutWeeks of CTMedication adherenceReceptor hypofunctionImpaired neuroplasticityPharmacodynamic variabilityNMDAR functionExtensive metabolizersTreatment periodPsychotic symptomsStable outpatientsCognitive impairmentGlyT1 occupancyTransporter 1CTNeuroplasticityCognitive training strategiesSchizophreniaComputerized CTCognitive performanceAugmentation studiesGreater improvement
2022
Training in LGBTQ-Affirmative Cognitive Behavioral Therapy: A Randomized Controlled Trial Across LGBTQ Community Centers
Pachankis JE, Soulliard ZA, van Dyk I, Layland EK, Clark KA, Levine DS, Jackson SD. Training in LGBTQ-Affirmative Cognitive Behavioral Therapy: A Randomized Controlled Trial Across LGBTQ Community Centers. Journal Of Consulting And Clinical Psychology 2022, 90: 582-599. PMID: 35901370, PMCID: PMC9434976, DOI: 10.1037/ccp0000745.Peer-Reviewed Original ResearchConceptsCognitive behavioral therapyMental health providersHealth providersBehavioral therapyEvidence-based mental health careMental health careSelf-reported cultural competenceLGBTQ community centersControlled TrialsMonths postbaselineCommunity centersPractice settingsHealth careCBT knowledgeSignificant differencesTherapyGreater improvementClinical vignettesBaselineTrialsPractice skillsParticipantsGreater uptakeCultural humilityTraining conditionsAddressing Chronic School Absenteeism Through Intensive Home-Based Psychiatric Treatment: An Examination of the IICAPS Program
Conway C, Decker L, Moffett S, Adnopoz J, Woolston J. Addressing Chronic School Absenteeism Through Intensive Home-Based Psychiatric Treatment: An Examination of the IICAPS Program. Child And Adolescent Social Work Journal 2022, 41: 95-106. DOI: 10.1007/s10560-022-00839-3.Peer-Reviewed Original ResearchIntensive home-based treatmentChronic school absenteeismConcurrent mental health issuesTreatment trajectoriesSchool absenteeismHome-based treatmentRate of absenceDifferential treatment effectsMental health issuesPhysical health outcomesClinical presentationHigh-risk youthSchool attendancePsychiatric treatmentClinical concernHealth outcomesPsychosocial adversityClinical diagnosisMinority of parentsSchool absenceProtective factorsHealth issuesTreatment effectsOne-thirdGreater improvementThe Impact of Mental Health Intensive Case Management on Functioning and Clinical Outcomes of Older Black and White Veterans With Serious Mental Illness
Browne J, Mohamed S. The Impact of Mental Health Intensive Case Management on Functioning and Clinical Outcomes of Older Black and White Veterans With Serious Mental Illness. American Journal Of Geriatric Psychiatry 2022, 30: 1183-1194. PMID: 35365385, DOI: 10.1016/j.jagp.2022.02.009.Peer-Reviewed Original ResearchConceptsSerious mental illnessIntensive case managementAnxiety/depressionClinical outcomesWhite veteransBlack veteransUse disordersMental illnessMental health recovery programsCase managementNational program evaluation dataDrug use disordersVeterans Health Administration programHigh-intensity servicesAlcohol use disorderSubstance use treatmentWhite older adultsGreater improvementService deliveryMedication managementBaseline differencesOutcome measuresSociodemographic factorsEqual-access settingSecondary analysisDeucravacitinib in Moderate to Severe Psoriasis: Clinical and Quality-of-Life Outcomes in a Phase 2 Trial
Thaçi D, Strober B, Gordon K, Foley P, Gooderham M, Morita A, Papp K, Puig L, Menter M, Colombo M, Elbez Y, Kisa R, Ye J, Napoli A, Wei L, Banerjee S, Merola J, Gottlieb A. Deucravacitinib in Moderate to Severe Psoriasis: Clinical and Quality-of-Life Outcomes in a Phase 2 Trial. Dermatology And Therapy 2022, 12: 495-510. PMID: 35025062, PMCID: PMC8850503, DOI: 10.1007/s13555-021-00649-y.Peer-Reviewed Original ResearchDermatology Life Quality IndexSevere plaque psoriasisPhase 2 trialPlaque psoriasisStatic Physician's Global AssessmentBody surface area involvementGlobal assessmentPhase 2 clinical trialLife outcomesComplete skin clearanceMethodsPost-hoc analysisPhysician global assessmentSurface area involvementNew oral therapiesLife Quality IndexMost efficacy measuresPromising new oral therapyGreater improvementSkin clearanceSevere psoriasisOral therapyPsoriasis AreaInvestigator assessmentClinical outcomesWeek 12
2021
Trends and geographical variation in population thriving, struggling and suffering across the USA, 2008–2017: a retrospective repeated cross-sectional study
Riley C, Herrin J, Lam V, Hamar B, Witters D, Liu D, Krumholz HM, Roy B. Trends and geographical variation in population thriving, struggling and suffering across the USA, 2008–2017: a retrospective repeated cross-sectional study. BMJ Open 2021, 11: e043375. PMID: 34261676, PMCID: PMC8281074, DOI: 10.1136/bmjopen-2020-043375.Peer-Reviewed Original ResearchConceptsPercentage of peopleCross-sectional studyWell-Being IndexMarked geographical variationNational HealthRetrospective analysisUS populationCross-sectional sampleLife evaluationGeographical disparitiesGreater improvementCantril SelfCurrent life satisfactionGeographical variationLife optimismNational averageInterventionConceptions of healthHealthPercentagePredictors of Time-in-Range (70–180 mg/dL) Achieved Using a Closed-Loop Control System
Schoelwer MJ, Kanapka LG, Wadwa RP, Breton MD, Ruedy KJ, Ekhlaspour L, Forlenza GP, Cobry EC, Messer LH, Cengiz E, Jost E, Carria L, Emory E, Hsu LJ, Weinzimer SA, Buckingham BA, Lal RA, Oliveri MC, Kollman CC, Dokken BB, Cherñavvsky DR, Beck RW, DeBoer MD, Gonder-Frederick L, Robic J, Voelmle M, Conschafter K, Morris K, Barnett C, Carr K, Hellmann J, Kime M, Todd Alonso G, Slover R, Berget C, Towers L, Lange S, Buckingham B, Maahs D, Lal R, Ekhlaspour L, Norlander L, Hood K, Town M, Weir C, Smith K, Hsu L, Shinksy D, Viana J, Cengiz E, Weinzimer S, Weyman K, Carria L, Zgorski M, Ruedy K, Beck R, Borgman S, Rusnak J, Kanapka L, Kollman C, Murphy C, Arreza-Rubin G, Green N, Kovatchev B, Brown S, Anderson S, Breton M, Laffel L, Pinsker J, Levy C, Kudva Y, Wadwa R, Buckingham B, Doyle III F, Renard E, Cobelli C, Reznik Y, Arreza-Rubin G, Lum J, Beck R, Ruedy K, Janicek R, Gabrielson D. Predictors of Time-in-Range (70–180 mg/dL) Achieved Using a Closed-Loop Control System. Diabetes Technology & Therapeutics 2021, 23: 475-481. PMID: 33689454, PMCID: PMC8252894, DOI: 10.1089/dia.2020.0646.Peer-Reviewed Original ResearchConceptsGlycemic controlLower TIROptimal glycemic controlType 1 diabetesPredictors of timeGreater improvementClinical characteristicsClinical predictorsFourth quartileMore insulinBody weightGlucose monitor dataExtension phaseMultivariate modelBolusStrongest predictorContinuous glucose monitor dataQuartileInsulinPredictorsChildrenParticipantsT1D.T1DDiabetes
2020
NSCLC: Integrating the “Yale model shared decision-making solution” into the practice setting.
Adelson K, Herbst R, Peterson P, Ingram M, Oliver B, Agrawal T, Davies M, Rudell E. NSCLC: Integrating the “Yale model shared decision-making solution” into the practice setting. Journal Of Clinical Oncology 2020, 38: 7054-7054. DOI: 10.1200/jco.2020.38.15_suppl.7054.Peer-Reviewed Original ResearchCheckpoint inhibitor therapyReasonable treatment optionMore side effectsLung cancer patientsCancer care settingsPatient-centered careTreatment decision processNational Quality ForumInhibitor therapyPatient-centric careCancer patientsTreatment optionsTreatment choicePost-intervention interviewsPatientsSide effectsPractice settingsQuality ForumSDM skillsHealthcare decisionsCareSDM processGreater improvementCliniciansTeam membersCoaching Intensity, Adherence to Essential Birth Practices, and Health Outcomes in the BetterBirth Trial in Utter Pradesh, India
Barnhart DA, Spiegelman D, Zigler CM, Kara N, Delaney MM, Kalita T, Maji P, Hirschhorn LR, Semrau KEA. Coaching Intensity, Adherence to Essential Birth Practices, and Health Outcomes in the BetterBirth Trial in Utter Pradesh, India. Global Health Science And Practice 2020, 8: ghsp-d-19-00317. PMID: 32127359, PMCID: PMC7108945, DOI: 10.9745/ghsp-d-19-00317.Peer-Reviewed Original ResearchConceptsEssential birth practicesSafe Childbirth ChecklistPerinatal health outcomesBirth attendantsHealth outcomesBetterBirth trialWorld Health Organization Safe Childbirth ChecklistBirth practicesQuality of careSustain behavior changeCoaching-based interventionBehavior changeFrequent coachingPerinatal mortalityBirth facilityAdherenceOutcomesGreater improvementAttendantsVisitsTrialsMonthsRegression modelsAssociationUtter PradeshGender Differences in Outcomes Following Specialized Intensive PTSD Treatment in the Veterans Health Administration
Stefanovics EA, Rosenheck RA. Gender Differences in Outcomes Following Specialized Intensive PTSD Treatment in the Veterans Health Administration. Psychological Trauma Theory Research Practice And Policy 2020, 12: 272-280. PMID: 31282719, DOI: 10.1037/tra0000495.Peer-Reviewed Original ResearchConceptsPosttraumatic stress disorderTotal PTSD symptom scoresPTSD symptomsNational program evaluation dataVeterans Health AdministrationVeterans Health Administration programGreater improvementPTSD symptom scoresIntensive PTSD treatmentSymptom scoresTreatment outcomesProgram participationMale veteransGender differencesHealth AdministrationPTSD treatmentFemale veteransPTSD programProgram evaluation dataMedium effect size differencesStress disorderGender-based differencesEffect size differencesSubstance useStudy sampleImpact of an Integrated EMDR Treatment Program for Children and Youth Exposed to Potentially Traumatic Events: The Village Collaborative Trauma Center
Whitson M, Champine R, Griffin A, Corto-Mergins C, Lusa J, Jaffe J, Hemmelgarn A, Bryden E, Clark K, Kaufman J. Impact of an Integrated EMDR Treatment Program for Children and Youth Exposed to Potentially Traumatic Events: The Village Collaborative Trauma Center. Journal Of EMDR Practice And Research 2020, 14: 206-215. DOI: 10.1891/emdr-d-20-00002.Peer-Reviewed Original ResearchPosttraumatic stress disorderTraumatic eventsProblem behaviorEye movement desensitizationSevere PTSD symptomsBody of researchPTSD symptomatologyPTSD symptomsReprocessing (EMDR) therapyStress disorderProblematic outcomesTreatment programYouthEMDRFuture researchYoung peopleOpen trialAdverse eventsGreater improvementTrauma centerClinic servicesSustained reductionInternalizingNumber of typesAdolescence
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply